Blackstone Inc. is an alternative asset management firm specializing in private equity, real estate, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage, seed, middle market, mature, late venture and later stage companies. It also provide capital markets services. The real estate segment specializes in opportunistic, core+ investments as well as debt investment opportunities collateralized by commercial real estate, and stabilized income-oriented commercial real estate across North America, Europe and Asia. The firm's corporate private equity business pursues transactions throughout the world across a variety of transaction types, including large buyouts, recapitalization, special situations, distressed mortgage loans, mid-cap buyouts, buy and build platforms, which involves multiple acquisitions behind a single management team and platform, and growth equity/development projects involving significant majority stakes in portfolio companies and minority investments in operating companies, shipping, real estate, corporate or consumer loans, and alternative energy greenfield development projects in energy and power, property, dislocated markets, shipping opportunities, financial institution breakups, re-insurance, and improving freight mobility, financial services, healthcare, life sciences, infrastructure, enterprise tech and consumer, as well as consumer technologies. The firm considers investment in Asia and Latin America. It seeks to invest between $0.25 million and $900 million per transaction. It invests in companies with enterprise value between $500 million and $5000 million. It has a three year investment period. The firm prefers to take majority and minority stakes. Its hedge fund business manages a broad range of commingled and customized fund solutions and its credit business focuses on loans, and securities of non-investment grade companies spread across the capital structure including senior debt, subordinated debt, preferred stock and common equity. Blackstone Inc. was founded in 1985 and is headquartered in New York, New York with additional offices across Asia, Europe, North America and Central America.

Blackstone Inc.

In a report released yesterday, Carey MacRury from Canaccord Genuity reiterated a Buy rating on Barrick Mining, with a price target of C$80.00. The...

Barrick Mining (B) Gets a Buy from Canaccord Genuity

An update from Blackboxstocks ( ($BLBX) ) is now available. On January 30, 2026, Blackboxstocks Inc. held a special meeting of stockholders to vote...

Blackboxstocks Shareholders Approve Merger Proposals, Reject Reverse Split

An update from Blackboxstocks ( ($BLBX) ) is now available. On February 2, 2026, Blackboxstocks Inc. held its 2025 Annual Meeting of Stockholders, ...

Blackboxstocks Shareholders Approve Directors and Auditor Slate

Third Coast Bancshares ( ($TCBX) ) has provided an announcement. On February 1, 2026, Third Coast Bancshares, Inc. completed its previously announc...

Third Coast Bancshares Completes Keystone Merger, Expands Texas Footprint

In a report released today, Michael Lewis from Truist Financial maintained a Hold rating on BXP, with a price target of $70.00. According to TipRan...

BXP (BXP) Receives a Hold from Truist Financial

Brambles ( ($AU:BXB) ) has issued an update. Brambles Limited has notified the ASX of a change in Director Graham Chipchase’s interests in the comp...

Brambles Updates Market on Change in Director Graham Chipchase’s Shareholdings

Imagion Biosystems Ltd. ( ($AU:IBX) ) has issued an announcement. Imagion Biosystems has submitted its first Investigational New Drug application t...

Imagion Biosystems Files IND with FDA for Phase 2 MagSense HER2 Breast Cancer Trial

Argus Research analyst Jim Kelleher maintained a Buy rating on Barrick Mining on January 28. The company’s shares closed last Friday at C$71.86. Ac...

Barrick Mining (B) Receives a Rating Update from a Top Analyst

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Nasdaq (NDAQ – Research Report) and Blackstone Grou...

Analysts’ Opinions Are Mixed on These Financial Stocks: Nasdaq (NDAQ) and Blackstone Group (BX)

Abacus Global Management ( ($ABX) ) has shared an update. On January 30, 2026, Abacus Global Management announced that its board of directors had a...

Abacus Global Management Announces New Share Repurchase Program

In a report released today, Craig Siegenthaler from Bank of America Securities maintained a Buy rating on Blackstone Group, with a price target of ...

Blackstone Group (BX) Receives a Buy from Bank of America Securities

Bioxyne Limited ( ($AU:BXN) ) has provided an announcement. Bioxyne Limited has applied for quotation on the ASX of 14,480,556 new fully paid ordin...

Bioxyne Seeks ASX Quotation for 14.5 Million New Shares Issued Under Incentive Plan

In a report released yesterday, Bennett Moore from J.P. Morgan initiated coverage with a Buy rating on Barrick Mining and a price target of $68.00....

New Buy Rating for Barrick Mining (B), the Basic Materials Giant

Bioxyne Limited ( ($AU:BXN) ) has shared an announcement. Bioxyne Limited has appointed Pitcher Partners in Brisbane as its new external auditor fo...

Bioxyne Switches Auditor to Support International Expansion

An update from Robex Resources ( ($TSE:RBX) ) is now available. In the December 2025 quarter, Robex Resources marked a major operational milestone ...

Robex Hits First Gold at Kiniero and Advances Merger in Push to Mid-Tier Status

Bendigo & Adelaide Bank ( ($AU:BEN) ) just unveiled an update. Bendigo and Adelaide Bank has scheduled the release of its half-year financial resul...

Bendigo and Adelaide Bank Sets Date for 1H26 Results and Investor Briefing

An announcement from ABx Group Limited ( ($AU:ABX) ) is now available. ABx Group’s December 2025 quarter marked key advances across its rare earths...

ABx Group Advances High-Value Rare Earths and Bauxite Projects as Funding Secured

Hbx Group International Plc ( ($ES:HBX) ) has provided an announcement. HBX Group reported first-quarter 2026 revenue of €170 million, up 5% at con...

HBX Group Posts Strong Q1 TTV Growth, Confirms 2026 Outlook and Buyback Plan

Hbx Group International Plc ( ($ES:HBX) ) has provided an update. HBX Group International Plc reported first-quarter revenue of €170 million, up 5%...

HBX Group Posts Strong Q1 Growth, Backs 2026 Outlook and Launches €100m Buyback

Bioxyne Limited ( ($AU:BXN) ) has provided an announcement. Bioxyne Limited has released a presentation of its second-quarter FY2026 results, empha...

Bioxyne Flags Q2 FY2026 Results Presentation as Informational Only, Not Investment Offer

Bank of Queensland ( ($AU:BOQ) ) just unveiled an update. Bank of Queensland has disclosed a change in the security holdings of director Patrick Al...

Bank of Queensland Director Patrick Allaway Receives Additional Equity Awards

Bank of Queensland ( ($AU:BOQ) ) has shared an announcement. Bank of Queensland Limited has notified the market of the issue of 1,202,804 unquoted ...

Bank of Queensland Issues Over 1.2 Million Unquoted Performance Rights Under Incentive Plan

VBX Limited ( ($AU:VBX) ) has provided an update. VBX Limited has announced material enhancements to the scope of its Definitive Feasibility Study ...

VBX Upscales Wuudagu DFS With Higher Mining Rates and Lower-Cost Infrastructure

Imagion Biosystems Ltd. ( ($AU:IBX) ) has shared an update. Imagion Biosystems has completed manufacturing and independent analytical testing of it...

Imagion Advances MagSense HER2 Program Toward FDA IND and Bolsters US Leadership

Citi analyst Thomas Strong maintained a Buy rating on Bank of Queensland today and set a price target of A$7.15. According to TipRanks, Strong is a...

Bank of Queensland  (BKQNF) Receives a Buy from Citi

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on BXP (BXP – Research Report) and AGNC Investment (...

Analysts Conflicted on These Real Estate Names: BXP (BXP) and AGNC Investment (AGNC)

In a report released yesterday, Madeleine Williams from Canaccord Genuity maintained a Buy rating on Botanix Pharmaceuticals Limited, with a price ...

Canaccord Genuity Sticks to Their Buy Rating for Botanix Pharmaceuticals Limited (BOT)

RBC Capital analyst Owen Birrell maintained a Buy rating on Brambles on January 26 and set a price target of A$28.50. According to TipRanks, Birrel...

RBC Capital Sticks to Its Buy Rating for Brambles  (BMBLF)

Bank of Queensland ( ($AU:BOQ) ) has issued an update. Bank of Queensland has appointed its Chief Transformation and Operations Officer, Rod Finch,...

Bank of Queensland Promotes Transformation Chief Rod Finch to CEO

In a report released yesterday, from Berenberg Bank reiterated a Buy rating on Tritax Big Box REIT, with a price target of p230.00. The company’s s...

Berenberg Bank Reaffirms Their Buy Rating on Tritax Big Box REIT (BBOX)

In a report released on January 23, Andrew Charles from TD Cowen maintained a Hold rating on Jack In The Box, with a price target of $16.00. The co...

TD Cowen Reaffirms Their Hold Rating on Jack In The Box (JACK)

Knorr-Bremse AG received a Hold rating and price target from DZ BANK AG analyst Holger Schmidt yesterday. Schmidt covers the Industrials sector, fo...

Knorr-Bremse AG (KBX) was downgraded to a Hold Rating at DZ BANK AG

VBX Limited ( ($AU:VBX) ) just unveiled an update. VBX Limited has reported significantly improved beneficiation results from metallurgical optimis...

VBX Boosts Wuudagu Bauxite Recoveries, Eyes Higher Production and Lower Costs

In a report released today, Mike Prew from Jefferies maintained a Buy rating on Tritax Big Box REIT, with a price target of p190.00. Prew covers th...

Tritax Big Box REIT (BBOX) Receives a Buy from Jefferies

Vanguard Group Inc. is pushing harder outside the U.S. as its non-U.S. assets pass $1 trillion. The firm now manages more than $12 trillion in tota...

Vanguard Group’s $1 Trillion Global Push Signals More Fee Pressure

U.S. stocks finished the week mixed as gains in technology shares helped offset weakness in financial stocks and rising rate pressure. The Dow Jone...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 25

In a report released on January 22, Julian Livingston-Booth from Kepler Capital maintained a Buy rating on Tritax Big Box REIT, with a price target...

Kepler Capital  Reaffirms Their Buy Rating on Tritax Big Box REIT (BBOX)

In a report released on January 22, Logan Reich from RBC Capital maintained a Buy rating on Jack In The Box, with a price target of $25.00. The com...

RBC Capital Keeps Their Buy Rating on Jack In The Box (JACK)

The latest announcement is out from BioNxt Solutions ( ($TSE:BNXT) ). BioNxt Solutions Inc. has proposed a shares-for-debt transaction with arm’s l...

BioNxt Moves to Retire $2.7 Million in Debenture Debt via Share Issuance

Barclays analyst Brendan Lynch maintained a Buy rating on BXP today and set a price target of $81.00. According to TipRanks, Lynch is an analyst wi...

Barclays Keeps Their Buy Rating on BXP (BXP)

Shore Capital analyst reiterated a Buy rating on Tritax Big Box REIT yesterday. The company’s shares closed yesterday at p162.70. The word on The S...

Tritax Big Box REIT (BBOX) Gets a Buy from Shore Capital

An update from ABx Group Limited ( ($AU:ABX) ) is now available. ABx Group has reported highly successful column leach test results on 26-kilogram ...

ABx Heap Leach Tests Exceed Expectations at Deep Leads Rare Earth Project

MBX Biosciences, Inc. ( ($MBX) ) has shared an announcement. On January 20, 2026, MBX Biosciences expanded its board of directors to eight members ...

MBX Biosciences Appoints Laurie Stelzer to Board, Audit Chair

Analysts have been eager to weigh in on the Financial sector with new ratings on Bendigo & Adelaide Bank (BXRBF – Research Report) and Assured Guar...

Analysts’ Opinions Are Mixed on These Financial Stocks: Bendigo & Adelaide Bank (OtherBXRBF) and Assured Guaranty (AGO)

An update from Australian Silica Quartz Group ( ($AU:ASQ) ) is now available. Australian Silica Quartz Group has reported encouraging results from ...

Australian Silica Quartz Reports Strong Quartz Grades and Advances High-Purity Trials

An update from Botanix Pharmaceuticals Limited ( ($AU:BOT) ) is now available. Botanix Pharmaceuticals has opened registration for an investor webi...

Botanix Opens Investor Webinar to Detail Quarterly Performance and Sofdra Progress

The latest update is out from Third Coast Bancshares ( ($TCBX) ). On January 21, 2026, Third Coast Bancshares reported strong results for the fourt...

Third Coast Bancshares Reports Record 2025 Earnings Growth

The latest update is out from BioNxt Solutions ( ($TSE:BNXT) ). BioNxt Solutions has reported final results from a preclinical study in miniature p...

BioNxt’s Sublingual Cladribine Film Delivers 40% Higher Exposure in Preclinical MS Study

UBS analyst Andre Kukhnin maintained a Buy rating on Knorr-Bremse AG yesterday. The company’s shares closed yesterday at €96.65. According to TipRa...

UBS Sticks to Its Buy Rating for Knorr-Bremse AG (KBX)

ABx Group Limited ( ($AU:ABX) ) just unveiled an announcement. ABx Group has disclosed that it inadvertently breached ASX Listing Rule 7.1 by issui...

ABx Group Discloses Inadvertent Breach of ASX Placement Capacity Rule

The latest update is out from Bank of Queensland ( ($AU:BOQ) ). Bank of Queensland has released its quarterly APRA Basel III Pillar 3 disclosures f...

Bank of Queensland Publishes Basel III Pillar 3 Quarterly Disclosures

BioNxt Solutions ( ($TSE:BNXT) ) has provided an update. BioNxt Solutions has reported successful results from a comparative pharmacokinetics study...

BioNxt’s Cladribine Film Shows Superior Bioavailability in Preclinical MS Study

An announcement from BioNxt Solutions ( ($TSE:BNXT) ) is now available. BioNxt Solutions has reported significant progress in developing its propri...

BioNxt Advances Thin-Film Drug Platform With First Patent for Sublingual Cladribine

The latest announcement is out from Botanix Pharmaceuticals Limited ( ($AU:BOT) ). Botanix Pharmaceuticals Ltd has applied for quotation on the ASX...

Botanix Seeks ASX Quotation for 1.77 Million New Shares After Option Conversions

ABx Group Limited ( ($AU:ABX) ) has provided an announcement. ABx Group has reported encouraging results from a 38-hole scout drilling program at i...

ABx Extends High-Grade Rare Earth Discoveries in Tasmania as Australia Targets Critical Minerals

Turmalina Metals Corp ( ($TSE:KCP) ) has issued an update. King Copper Discovery Corp. has closed a non-brokered private placement of 25 million un...

King Copper Discovery Raises $15 Million in Private Placement for South American Copper Projects

Barrick Mining ( ($TSE:ABX) ) just unveiled an announcement. Barrick Mining Corporation has appointed Helen Cai as Senior Executive Vice President ...

Barrick Names Helen Cai as New Chief Financial Officer

In a report released yesterday, Sarah Roberts from Barclays maintained a Buy rating on Hbx Group International Plc. The company’s shares closed yes...

Hbx Group International Plc (HBX) Gets a Buy from Barclays

Third Coast Bancshares ( ($TCBX) ) just unveiled an announcement. On October 22, 2025, Third Coast Bancshares, Inc. agreed to a reorganization with...

Third Coast Bancshares addresses merger disclosure challenges

Essex Minerals ( ($TSE:OPTG) ) has shared an announcement. Optegra Ventures Inc. has warned of a delay in filing its annual consolidated financial ...

Optegra Ventures Seeks Management Cease Trade Order Amid Audit Filing Delay

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MBX Biosciences, Inc. (MBX – Research Report), Tel...

Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Teladoc (TDOC) and Pfizer (PFE)

Bioxyne Limited ( ($AU:BXN) ) just unveiled an announcement. Bioxyne Limited has informed the ASX that it is cancelling a previously lodged notice ...

Bioxyne Cancels Redundant ASX Notice on Lapsed Performance Rights

Barclays analyst Vladimir Sergievskiy maintained a Sell rating on Knorr-Bremse AG yesterday. The company’s shares closed today at €99.30. According...

Barclays Remains a Sell on Knorr-Bremse AG (KBX)

In a report released on January 13, Rishi Jaluria from RBC Capital maintained a Buy rating on Dropbox, with a price target of $35.00. The company’s...

RBC Capital Reaffirms Their Buy Rating on Dropbox (DBX)

Citi analyst Thomas Strong upgraded Bank of Queensland to a Buy today and set a price target of A$7.15. Strong covers the Financial sector, focusin...

Positive Report for Bank of Queensland  (BKQNF) from Citi

Citi analyst Thomas Strong downgraded Bendigo & Adelaide Bank to a Sell today and set a price target of A$10.25. Strong covers the Financial sector...

Citi downgrades Bendigo & Adelaide Bank (BXRBF) to a Sell

Wallbox ( ($WBX) ) has issued an update. On January 14, 2026, Wallbox N.V. announced that Institut Català de Finances, through its vehicle IFEM, ha...

Wallbox Secures Non-Binding €5 Million Equity Commitment from Catalan Public Lender

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on MBX Biosciences, Inc., with a price target of $50.00. Ac...

MBX Biosciences, Inc. (MBX) Receives a Buy from Stifel Nicolaus

J.P. Morgan analyst Phil Buller maintained a Hold rating on Knorr-Bremse AG today and set a price target of €94.70. Buller covers the Industrials s...

Knorr-Bremse AG (KBX) Receives a Hold from J.P. Morgan

Bioxcel Therapeutics ( ($BTAI) ) has shared an update. On January 12, 2026, BioXcel Therapeutics announced the appointment of Mark Pavao as Interim...

BioXcel Therapeutics names interim CCO amid IGALMI expansion

MBX Biosciences, Inc. ( ($MBX) ) just unveiled an update. On January 11, 2026, MBX Biosciences announced it would present a 2026 outlook and busine...

MBX Biosciences Highlights 2026 Outlook and Pipeline Progress

U.S. stocks ended the week higher as investors balanced softer hiring data with new government support for housing and stronger momentum in energy ...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 11

In a report released on January 8, William Mackie from Kepler Capital maintained a Buy rating on Knorr-Bremse AG, with a price target of €110.00. T...

Kepler Capital  Remains a Buy on Knorr-Bremse AG (KBX)

In a report released on January 8, Julian Livingston-Booth from Kepler Capital maintained a Buy rating on Tritax Big Box REIT, with a price target ...

Tritax Big Box REIT (BBOX) Gets a Buy from Kepler Capital

Greenbrier Companies (($GBX)) has held its Q1 earnings call. Read on for the main highlights of the call. Greenbrier’s Earnings Call Balances Solid...

Greenbrier Earnings Call: Strong Results, Cautious Outlook

An update from Abacus Global Management ( ($ABX) ) is now available. In a shareholder letter released on January 8, 2026, Abacus Global Management ...

Abacus Global Highlights Record 2025 Results and Strategic Shift

In a report released today, Gael De-Bray from Deutsche Bank maintained a Buy rating on Knorr-Bremse AG, with a price target of €108.00. De-Bray cov...

Deutsche Bank  Reaffirms Their Buy Rating on Knorr-Bremse AG (KBX)

Barclays analyst Benjamin Budish maintained a Hold rating on Blackstone Group today and set a price target of $171.00. Budish covers the Financial ...

Blackstone Group (BX) Gets a Hold from Barclays

Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Blackstone Group yesterday. The company’s shares closed yesterday at $155.30. Acco...

Blackstone Group (BX) Receives a Buy from Morgan Stanley

Bank of Queensland ( ($AU:BOQ) ) just unveiled an announcement. Bank of Queensland has notified the market that 609,885 ordinary fully paid shares ...

Bank of Queensland Issues 609,885 New Shares From Conversion of Unquoted Securities

An update from Imagion Biosystems Ltd. ( ($AU:IBX) ) is now available. Imagion Biosystems has issued 3,048,484 new fully paid ordinary shares at a ...

Imagion Biosystems Issues New Shares on Mercer Note Conversion, Flags Imminent HER2+ Trial Filing

An update from Imagion Biosystems Ltd. ( ($AU:IBX) ) is now available. Imagion Biosystems Limited has applied to the ASX for quotation of 3,048,484...

Imagion Biosystems Seeks ASX Quotation for 3.0 Million New Shares

J.P. Morgan analyst Akash Gupta maintained a Hold rating on Knorr-Bremse AG today and set a price target of €94.70. According to TipRanks, Gupta is...

J.P. Morgan Sticks to Their Hold Rating for Knorr-Bremse AG (KBX)

An update from Bendigo & Adelaide Bank ( ($AU:BEN) ) is now available. Bendigo and Adelaide Bank has applied for quotation on the ASX of 334 additi...

Bendigo and Adelaide Bank Seeks ASX Quotation for New Employee Scheme Shares

The latest update is out from Bendigo & Adelaide Bank ( ($AU:BEN) ). Bendigo and Adelaide Bank has notified the market that 38,606 performance righ...

Bendigo and Adelaide Bank Reports Lapse of 38,606 Performance Rights

In a report released today, Ross Bennett from Morgans maintained a Buy rating on VBX Limited, with a price target of A$2.10. Bennett covers the Bas...

Morgans Keeps Their Buy Rating on VBX Limited (VBX)

Imagion Biosystems Ltd. ( ($AU:IBX) ) has issued an announcement. Imagion Biosystems has completed the conversion of the remaining first tranche of...

Imagion Biosystems Extinguishes First Mercer Tranche and Restructures Second Convertible Note

An announcement from Bank of Queensland ( ($AU:BOQ) ) is now available. Bank of Queensland has notified the market that a total of 36,727 deferred ...

Bank of Queensland Announces Lapse of 36,727 Deferred and Award Rights

Investors have a range of opportunities to invest in pre-IPO stocks, in the early stage of the business, as it grows and as it gets set to list. Bu...

7 Ways to Invest in Pre-IPO Stock

Barrick Mining ( ($TSE:ABX) ) has issued an announcement. Barrick Mining Corporation announced it will publish its full-year and fourth-quarter 202...

Barrick Mining Sets February 5 Date for Full-Year and Q4 2025 Results

The latest update is out from Bright Smart Securities & Commodities Group Limited ( ($HK:1428) ). Bright Smart Securities & Commodities Group Limit...

Bright Smart Details HK$80.6 Million Right-of-Use Assets from Amended Tenancy Deals

The latest announcement is out from Mobix Labs ( ($MOBX) ). On January 6, 2026, Mobix Labs, Inc. entered into securities purchase agreements for a ...

Mobix Labs Announces Public Equity Offering for Working Capital

In a report released today, Brendan Sproules from Goldman Sachs upgraded Bendigo & Adelaide Bank to a Buy, with a price target of A$11.32. Sproules...

Bendigo & Adelaide Bank (BXRBF) was upgraded to a Buy Rating at Goldman Sachs

VerifyMe, Mobix Labs, and Hyperscale Data are the 3&nbsp;Penny Stocks&nbsp;to watch on January 6, 2026, based on&nbsp;TipRanks’ Penny Stock Screene...

3 Penny Stocks to Watch Now, 1/6/26

Mobix Labs ( ($MOBX) ) has provided an update. On January 5, 2026, Mobix Labs, Inc. announced that it intended to launch a public offering of share...

Mobix Labs Prices Public Offering to Bolster Liquidity

Imagion Biosystems Ltd. ( ($AU:IBX) ) has shared an update. Imagion Biosystems has disclosed a change in director Robert Romeo Proulx’s interests, ...

Imagion Biosystems Director Reshapes Equity Holdings With Share Acquisition and Rights Lapse

Imagion Biosystems Ltd. ( ($AU:IBX) ) just unveiled an announcement. Imagion Biosystems has issued 1.4 million fully paid ordinary shares at a deem...

Imagion Biosystems Issues New Shares on Vesting of Performance Rights, Reaffirms Imminent HER2+ FDA Filing

Imagion Biosystems Ltd. ( ($AU:IBX) ) just unveiled an announcement. Imagion Biosystems Limited has applied to the ASX for quotation of 1.4 million...

Imagion Biosystems Seeks ASX Quotation for 1.4 Million New Shares

In a report released today, Leo Carrington from Citi maintained a Buy rating on Hbx Group International Plc, with a price target of €14.50. Carring...

Hbx Group International Plc (HBX) Receives a Buy from Citi

VBX Limited ( ($AU:VBX) ) has issued an update. VBX Limited has reported strong exploration drilling results from the previously undrilled Wuudagu ...

Current Quarter	$1.44	Next Quarter	$1.57
Current Year	$6.43	Next Year	$8.01
QoQ Growth	+9.0%	YoY Growth	+24.6%
3Y EPS CAGR	N/A	Target Price	$178.05
Consensus	Buy	Upside	+26.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BX	$141.28	-0.80%	4.41M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BX	$141.28	-0.8%	4.41M
3
4
5
6

BX

BX

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Blackstone Inc. Data in Excel

Get Blackstone Inc. Data in Excel